EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Role of PI3K/AKT/mTOR Signaling in Tumor Radioresistance and Advances in Inhibitor Research

Jian Zhan, Manfred Jücker iD

International Journal of Molecular Sciences · 17.07.2025 · 26 (14) · 6853

DOI: 10.3390/ijms26146853 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 17.07.2025. Verfasst von Jian Zhan und 1 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biochemistry and Signal Transduction, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246 Hamburg, Germany. Hauptthemen laut MEDLINE: TOR Serine-Threonine Kinases, Neoplasms, Proto-Oncogene Proteins c-akt, Signal Transduction. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 156 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China Scholarship Council, Hamburger Krebsgesellschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer is a major threat to human health, and radiotherapy is a key treatment method. However, its effectiveness is often limited by tumor radioresistance. The PI3K/AKT/mTOR signaling pathway is commonly dysregulated in cancers and plays a significant role in radioresistance, though its exact mechanisms remain unclear. This review discusses how this pathway regulates tumor radioresistance and highlights recent progress in the development of related inhibitors in preclinical and clinical studies. These findings aim to guide clinical treatment strategies and provide new approaches to overcoming radioresistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TOR Serine-Threonine KinasesNeoplasmsProto-Oncogene Proteins c-aktSignal TransductionRadiation TolerancePhosphatidylinositol 3-KinasesHumansAnimalsProtein Kinase Inhibitors

Stichwörter der Autor:innen

AKTPI3KmTORradioresistance

Substanzen

TOR Serine-Threonine KinasesProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesMTOR protein, humanProtein Kinase Inhibitors

Autor:innen und Institutionen

  • Institute of Biochemistry and Signal Transduction, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246 Hamburg, Germany.

ORCID-Profile: Manfred Jücker

Förderung

  • China Scholarship Council
  • Hamburger Krebsgesellschaft

Zitieren

APA

Zhan, J., & Jücker, M. (2025). The Role of PI3K/AKT/mTOR Signaling in Tumor Radioresistance and Advances in Inhibitor Research. International Journal of Molecular Sciences, 26(14), 6853. https://doi.org/10.3390/ijms26146853

Vancouver

Zhan J, Jücker M. The Role of PI3K/AKT/mTOR Signaling in Tumor Radioresistance and Advances in Inhibitor Research. International Journal of Molecular Sciences. 2025;26(14):6853. doi:10.3390/ijms26146853

BibTeX
@article{Zhan2025,
  author = {Zhan, Jian and Jücker, Manfred},
  title = {The Role of PI3K/AKT/mTOR Signaling in Tumor Radioresistance and Advances in Inhibitor Research},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {14},
  pages = {6853},
  doi = {10.3390/ijms26146853}
}
Kostenlos starten →